SynopsisThe global Etodolac market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Etodolac is estimated to increase from $ million in 2023 .....
SynopsisThe global Allisartan Isoproxil market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Allisartan Isoproxil is estimated to increase.....
SynopsisThe global Apatinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Apatinib is estimated to increase from $ million in 2023 .....
SynopsisThe global Nivolumab market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Nivolumab is estimated to increase from $ million in 202.....
SynopsisThe global Durvalumab market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Durvalumab is estimated to increase from $ million in 2.....
SynopsisThe global Pembrolizumab market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Pembrolizumab is estimated to increase from $ millio.....
SynopsisThe global Atezolizumab market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Atezolizumab is estimated to increase from $ million .....
SynopsisThe global Avelumab market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Avelumab is estimated to increase from $ million in 2023 .....
SynopsisThe global Imrecoxib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Imrecoxib is estimated to increase from $ million in 202.....
SynopsisThe global Iguratimod market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Iguratimod is estimated to increase from $ million in 2.....
